期刊文献+

肝移植术后排斥合并高血糖的诊治和用药的实践与思考 被引量:1

Diagnosis and individualized drug therapy for the rejection with hyperglycemia after liver Transplantation
下载PDF
导出
摘要 目的:为肝移植术后发生排斥反应合并高血糖的患者建立个体化用药策略。方法:临床药师参与1例肝移植术后发生排斥反应、并发高血糖患者的诊治过程,与医生通力协作,根据患者肝功能变化,利用治疗药物监测和他克莫司-五酯胶囊临床药物相互作用,及时调整给药方案,改善患者预后。结果:该患者排斥反应和高血糖得以纠正,恢复良好,顺利出院。结论:临床药师应积极参与临床诊疗,为患者制定个体化用药策略,降低免疫抑制剂毒副作用,减少不良事件发生,提升患者移植“后时代”的长期生存质量。 AIM:To establish individualized drug therapy strategy for patients with rejection and hy-perglycemia after liver transplantation.METHODS:Clinical pharmacist collaborated with the surgeons and participated in the diagnosis and treatment of rejection and hyperglycemia after liver transplanta-tion.Taking together liver function,therapeutic drug monitoring,drug-drug interactions between tacrolimus and wuzhi capsule,individualized drug therapy was adapted to improve the prognosis.RE-SULTS:The patient recovered well and survived in good health till now.CONCLUSION:It is highly sug-gested that clinical pharmacists actively involved in treatment of more severe and difficult-to-treat dis-ease and design the individualized dosing regi-mens.This will largely contribute in reduced ad-verse drug reaction,improved safety and effective-ness in drug use as well as the quality of life in the"post-transplantation era".
作者 陈以宁 肖云 韩晓雨 黄璐璐 马景胜 熊寒斌 傅毓 汪保林 郭晓晖 钟林 敖检根 何佳珂 CHEN Yining;XIAO Yun;HAN Xiaoyu;HUANG Lulu;MA Jingsheng;XIONG Hanbin;FU Yu;WANG Baolin;GUO Xiaohui;ZHONG Lin;AO Jiangen;HE Jiake(Department of Pharmacy,the Second Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi,China;Institute of Clinical Pharmacology,Nanchang University,Nanchang 330031,Jiangxi,China;School of Pharmacy,Nanchang University,Nanchang 330006,Jiangxi,China;Department of Organ Transplantation,the Second Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi,China;Department of Pharmacy,Nanchang County People's Hospital,Nanchang 330200,Jiangxi,China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2023年第5期550-555,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金(82160707,82060677,81603188) 中华医学会临床药学分会-吴阶平基金会科研基金(LCYX-Q006/320.6750.19090-16) 江西省自然科学基金青年重点/一般项目(20202ACB216005) 江西省主要学科学术和技术带头人培养计划-青年人才项目(20204BCJL23053)。
关键词 肝移植术后 排斥反应 高血糖 个体化用药 liver transplantation rejection hy-perglycemia individualized medicine
  • 相关文献

参考文献23

二级参考文献403

共引文献222

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部